Chemoinformaics analysis of 1-OXO-3,4-DIHYDROISOCHROMENE-5-CARBALDEHYDE
| Molecular Weight | 176.171 | nRot | 1 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 18 |
| Exact Molecular Weight | 176.047 | nRing | 2 |
| Solubility: LogS | -2.492 | nHRing | 1 |
| Solubility: LogP | -0.686 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 24.4403 |
| nHD | 0 | BPOL | 11.4977 |
| QED | 0.42 |
| Synth | 4.011 |
| Natural Product Likeliness | 1.461 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.868 |
| HIA | 0.705 |
| CACO-2 | -5.784 |
| MDCK | 0.000116402 |
| BBB | 0.51 |
| PPB | 0.269631 |
| VDSS | 0.353 |
| FU | 0.616755 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.093 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.625 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.475 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.321 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.037 |
| CL | 1.598 |
| T12 | 0.588 |
| hERG | 0.01 |
| Ames | 0.689 |
| ROA | 0.183 |
| SkinSen | 0.172 |
| Carcinogencity | 0.724 |
| EI | 0.008 |
| Respiratory | 0.029 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.870349 |